The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More

The United States Food and Drug Administration has officially granted approval to Scholar Rock for Isemblyd (apitegromab), establishing a monumental…
Read More
Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…
Read More
The traditional medical consensus that damage to the central nervous system is inherently permanent has been challenged by a landmark…
Read More